SD

Sarojben Dashrath Agravat

Active Director Designated Partner DIN 11733645
DIN 11733645 First appointment May 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Sarojben Dashrath Agravat

Data last updated:

Sarojben Dashrath Agravat is a Designated Partner at Vadodara Swasthya Super Speciality Hospital Llp (since 2026).

DIN 11733645
Primary Designation Designated Partner
First Appointment 21 May 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner21 May 20262026Active

Board colleagues of Sarojben Dashrath Agravat

NameDINCompanyDesignation
Dashrathbhai Jethiram Agravat08464180Vadodara Swasthya Super Speciality Hospital LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Vadodara Swasthya Super Speciality Hospital Llp
Premium access

Shareholding and investment profile for Sarojben Dashrath Agravat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sarojben Dashrath Agravat

Sarojben Dashrath Agravat currently holds 1 directorship: Vadodara Swasthya Super Speciality Hospital Llp (Designated Partner, since 21 May 2026).

Sarojben Dashrath Agravat was first appointed on 21 May 2026 as Designated Partner at Vadodara Swasthya Super Speciality Hospital Llp.

The current boards of Sarojben Dashrath Agravat's companies include Dashrathbhai Jethiram Agravat (Vadodara Swasthya Super Speciality Hospital Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available